End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.53 USD | -1.28% | +1.07% | +145.48% |
12/06 | Dianthus Therapeutics Secures US FDA Approval to Launch Phase 2 Study of DNTH103 in Multifocal Motor Neuropathy | MT |
12/06 | Dianthus Therapeutics Gets FDA Clearance for DNTH103 Phase 2 Trial | DJ |
Chart calendar Dianthus Therapeutics, Inc.
Upcoming events on Dianthus Therapeutics, Inc.
No events available
Past events on Dianthus Therapeutics, Inc.
06/06/2024 11:00 pm | Jefferies Global Healthcare Conference |
23/05/2024 06:30 pm | Annual General Meeting |
15/05/2024 04:50 am | BofA Securities Health Care Conference |
10/05/2024 01:31 am | Q1 2024 Earnings Release |
15/04/2024 | American Academy of Neurology Meeting |
22/03/2024 01:31 am | Q4 2023 Earnings Release |
05/03/2024 01:20 am | TD Cowen Health Care Conference |
07/02/2024 09:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
12/01/2024 12:00 am | JPMorgan Healthcare Conference |
28/11/2023 | Evercore ISI HealthCONx Conference |
14/11/2023 | Jefferies London Healthcare Conference |
10/11/2023 02:35 am | Q3 2023 Earnings Release |
06/11/2023 | Guggenheim Securities Inflammation & Immunology Conference |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 2,83 2,52 12.13% | 1,78 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -48,2 -63,0 23.48% | -77,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -43,6 -58,1 25.1% | -63,7 |
Net income Million USD | Released Forecast Spread | -28,5 | -43,6 -58,1 25.07% | -63,7 |
EPS USD | Released Forecast Spread | -7,10 | -8,45 -5,62 -50.46% | -2,16 |
Announcement Date | 01/08/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,92 0,25 269.6% | 0,46 0,44 4.15% | 0,87 0,37 135.33% | 0,31 | 0,31 | 0,31 | 0,32 | 0,32 |
EBIT Million USD | Released Forecast Spread | -15,8 -9,20 -71.38% | -13,0 -15,8 18.11% | -17,8 -14,7 -21.58% | -18,6 | -19,9 | -21,3 | -18,9 | -19,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,8 -8,31 -77.71% | -10,6 -15,2 30.38% | -13,7 -13,5 -1.81% | -15,0 | -16,3 | -18,6 | -15,6 | -16,6 |
Net income Million USD | Released Forecast Spread | -14,8 -8,31 -77.71% | -10,6 -15,2 30.38% | -13,7 -13,5 -1.81% | -15,0 | -16,3 | -18,6 | -15,6 | -16,6 |
EPS USD | Released Forecast Spread | -3,78 -0,56 -575% | -1,02 | -0,54 -0,44 -23.29% | -0,54 | -0,58 | -0,64 | -0,55 | -0,60 |
Announcement Date | 09/11/23 | 21/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Dianthus Therapeutics, Inc.
05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DNTH Stock
- Calendar Dianthus Therapeutics, Inc.